376 related articles for article (PubMed ID: 22201838)
1. PPAR gamma, bioactive lipids, and cancer progression.
Robbins GT; Nie D
Front Biosci (Landmark Ed); 2012 Jan; 17(5):1816-34. PubMed ID: 22201838
[TBL] [Abstract][Full Text] [Related]
2. Biology of PPAR gamma in cancer: a critical review on existing lacunae.
Krishnan A; Nair SA; Pillai MR
Curr Mol Med; 2007 Sep; 7(6):532-40. PubMed ID: 17896990
[TBL] [Abstract][Full Text] [Related]
3. Can PPAR gamma ligands be used in cancer therapy?
Rumi MA; Ishihara S; Kazumori H; Kadowaki Y; Kinoshita Y
Curr Med Chem Anticancer Agents; 2004 Nov; 4(6):465-77. PubMed ID: 15579013
[TBL] [Abstract][Full Text] [Related]
4. The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity.
Yousefnia S; Momenzadeh S; Seyed Forootan F; Ghaedi K; Nasr Esfahani MH
Gene; 2018 Apr; 649():14-22. PubMed ID: 29369787
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma in bladder cancer: a promising therapeutic target.
Mansure JJ; Nassim R; Kassouf W
Cancer Biol Ther; 2009 Apr; 8(7):6-15. PubMed ID: 19417560
[TBL] [Abstract][Full Text] [Related]
6. Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.
Nakano Y; Arima T; Tobita Y; Uchiyama M; Shimizu A; Takahashi H
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707656
[TBL] [Abstract][Full Text] [Related]
7. The role of peroxisome proliferator-activated receptor gamma in prostate cancer.
Elix C; Pal SK; Jones JO
Asian J Androl; 2018; 20(3):238-243. PubMed ID: 28597850
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer.
Wang Q; Imam MU; Yida Z; Wang F
Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503
[TBL] [Abstract][Full Text] [Related]
9. PPARγ Agonists in Combination Cancer Therapies.
Mrowka P; Glodkowska-Mrowka E
Curr Cancer Drug Targets; 2020; 20(3):197-215. PubMed ID: 31814555
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer.
Ferrari SM; Materazzi G; Baldini E; Ulisse S; Miccoli P; Antonelli A; Fallahi P
Curr Med Chem; 2016; 23(7):636-49. PubMed ID: 26844838
[TBL] [Abstract][Full Text] [Related]
11. Insights into Dynamic Mechanism of Ligand Binding to Peroxisome Proliferator-Activated Receptor γ toward Potential Pharmacological Applications.
Miyamae Y
Biol Pharm Bull; 2021; 44(9):1185-1195. PubMed ID: 34471046
[TBL] [Abstract][Full Text] [Related]
12. The role of peroxisome proliferator-activated receptor-γ in breast cancer.
Kotta-Loizou I; Giaginis C; Theocharis S
Anticancer Agents Med Chem; 2012 Nov; 12(9):1025-44. PubMed ID: 22583414
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.
Annicotte JS; Iankova I; Miard S; Fritz V; Sarruf D; Abella A; Berthe ML; Noël D; Pillon A; Iborra F; Dubus P; Maudelonde T; Culine S; Fajas L
Mol Cell Biol; 2006 Oct; 26(20):7561-74. PubMed ID: 17015477
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor γ agonists induce cell cycle arrest through transcriptional regulation of Kruppel-like factor 4 (KLF4).
Li S; Zhou Q; He H; Zhao Y; Liu Z
J Biol Chem; 2013 Feb; 288(6):4076-84. PubMed ID: 23275339
[TBL] [Abstract][Full Text] [Related]
15. The nuclear hormone receptor PPARγ as a therapeutic target in major diseases.
Schmidt MV; Brüne B; von Knethen A
ScientificWorldJournal; 2010 Nov; 10():2181-97. PubMed ID: 21057731
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Takada I; Makishima M
Expert Opin Ther Pat; 2020 Jan; 30(1):1-13. PubMed ID: 31825687
[No Abstract] [Full Text] [Related]
17. [PPARgamma and cancer].
Nakagama H
Nihon Rinsho; 2010 Feb; 68(2):323-9. PubMed ID: 20158104
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
Yang YC; Tsao YP; Ho TC; Choung IP
Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
[TBL] [Abstract][Full Text] [Related]
19. PPARgamma physiology and pathology in gastrointestinal epithelial cells.
Thompson EA
Mol Cells; 2007 Oct; 24(2):167-76. PubMed ID: 17978568
[TBL] [Abstract][Full Text] [Related]
20. PPARγ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes.
Kanakasabai S; Pestereva E; Chearwae W; Gupta SK; Ansari S; Bright JJ
PLoS One; 2012; 7(11):e50500. PubMed ID: 23185633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]